Table 1. Esophageal cancer incidence and mortality in Hebei province, 2011.
| Characteristics | Total (N=14,548) | HEC (N=6,477) (%) | MEC (N=8,071) (%) | P value |
| Demographics | ||||
| Age, yearsa | <0.001 | |||
| <30 | 269 | 139 (2.1) | 130 (1.6) | |
| 30–39 | 900 | 441 (6.8) | 459 (5.7) | |
| 40–49 | 2,833 | 1,353 (20.9) | 1,480 (18.5) | |
| 50–59 | 4,744 | 2,116 (32.7) | 2,628 (32.6) | |
| 60–69 | 3,795 | 1,616 (25.0) | 2,179 (27.0) | |
| 70–79 | 1,853 | 749 (11.6) | 1,104 (13.7) | |
| ≥80 | 133 | 57 (0.9) | 76 (0.9) | |
| Gender | 0.056 | |||
| Male | 6,859 | 3,111 (48.0) | 3,748 (46.4) | |
| Female | 7,689 | 3,366 (52.0) | 4,323 (53.6) | |
| Grade of hospitala | <0.001 | |||
| Grade 3 | 12,303 | 5,334 (82.7) | 6,969 (87.2) | |
| Grade 2 | 1,856 | 945 (14.7) | 911 (11.4) | |
| Grade 1 or below | 280 | 170 (2.6) | 110 (1.4) | |
| Use of antiemetic therapy | 0.146 | |||
| No | 153 | 77 (1.2) | 76 (0.9) | |
| Yes | 14,395 | 6,400 (98.8) | 7,995 (99.1) | |
| Purpose of antiemetic therapyb,c | ||||
| Prevent acute CINV | 13,085 | 5,842 (90.2) | 7,243 (89.7) | 0.364 |
| Prevent delayed CINV | 10,403 | 3,845 (59.4) | 6,558 (81.3) | <0.001 |
| Rescue therapy | 1,310 | 558 (8.6) | 752 (9.3) | 0.141 |
| Abbreviations: CINV, chemotherapy-induced nausea and vomiting; HEC, highly emetogenic chemotherapy; MEC, moderately emetogenic chemotherapy. Data are presented as n (%), and differences were tested using the chi-square test. a, data for age were missing for 21 patients and grade of hospital for 109 patients. b, data for 14,395 patients were included. c, patients could receive more than one type of therapy. | ||||